Acute dopamine and/or serotonin depletion does not modulate mismatch negativity (MMN) in healthy human participants

Psychopharmacology

Volumn 208, Issue 2, 2010, Pages 233-244

  Leung, Sumie ^a   Croft, Rodney J ^a,b   Guille, Valérie ^a   Scholes, Kirsty ^a   O'Neill, Barry V ^a   Phan, K Luan ^c   Nathan, Pradeep J ^d,e,f  

^a SWINBURNE UNIVERSITY OF TECHNOLOGY   (Australia)

^b UNIVERSITY OF WOLLONGONG   (Australia)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^e MONASH UNIVERSITY   (Australia)

^f GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Change detection; Cognition; Dopamine; Mismatch negativity; MMN; Monoamine; Schizophrenia; Serotonin; Tryptophan depletion; Tyrosine depletion

Indexed keywords

AMINO ACID TRANSPORTER; DOPAMINE; PHENYLALANINE; SEROTONIN; TRYPTOPHAN; TYROSINE;

ADULT; AMINO ACID TRANSPORT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOPAMINE UPTAKE; DOPAMINERGIC TRANSMISSION; DOUBLE BLIND PROCEDURE; ELECTRODE; HUMAN; HUMAN EXPERIMENT; LATENT PERIOD; MALE; MISMATCH NEGATIVITY; NEUROTRANSMISSION; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEROTONIN RELEASE; SEROTONIN UPTAKE; SEROTONINERGIC SYSTEM; COMPARATIVE STUDY; CONTINGENT NEGATIVE VARIATION; ELECTROENCEPHALOGRAPHY; METABOLISM; NERVE TRACT; REACTION TIME; TIME;

ADULT; CONTINGENT NEGATIVE VARIATION; CROSS-OVER STUDIES; DOPAMINE; DOUBLE-BLIND METHOD; ELECTROENCEPHALOGRAPHY; HUMANS; MALE; NEURAL PATHWAYS; PHENYLALANINE; REACTION TIME; SEROTONIN; TIME FACTORS; TRYPTOPHAN; TYROSINE; YOUNG ADULT;

EID: 77449146990     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-009-1723-0     Document Type: Article

References (79)

1. A Abi-Dargham M Laruelle GK Aghajanian D Charney J Krystal 1997 The role of serotonin in the pathophysiology and treatment of schizophrenia J Neuropsychiatry Clin Neurosci 9 1 17 1:CAS:528:DyaK2sXhtVert7Y%3D 9017523
2. T Baldeweg A Klugman J Gruzelier SR Hirsch 2004 Mismatch negativity potentials and cognitive impairment in schizophrenia Schizophr Res 69 203 217 10.1016/j.schres.2003.09.009 15469194
3. C Benkelfat MA Ellenbogen P Dean RM Palmour SN Young 1994 Mood-lowering effect of tryptophan depletion. Enhanced susceptibility in young men at genetic risk for major affective disorders Arch Gen Psychiatry 51 687 697 1:CAS:528:DyaK2cXmslyitrg%3D 8080345
4. E Bramon RJ Croft C McDonald GK Virdi JG Gruzelier T Baldeweg PC Sham S Frangou RM Murray 2004 Mismatch negativity in schizophrenia: a family study Schizophr Res 67 1 10 10.1016/S0920-9964(03)00132-4 14741319
5. A Breier 1995 Serotonin, schizophrenia and antipsychotic drug action Schizophr Res 14 187 202 10.1016/0920-9964(94)00043-8 1:STN:280: DyaK2M3otl2msw%3D%3D 7539288
6. LL Carpenter GM Anderson GH Pelton JA Gudin PD Kirwin LH Price GR Heninger CJ McDougle 1998 Tryptophan depletion during continuous CSF sampling in healthy human subjects Neuropsychopharmacology 19 26 35 10.1016/S0893-133X(97) 00198-X 1:CAS:528:DyaK1cXjsVOru7c%3D 9608574
7. SV Catts AM Shelley PB Ward B Lieber N McConaghy S Andrews PT Michie 1995 Brain potential evidence for an auditory sensory memory deficit in schizophrenia Am J Psychiatry 152 213 219 1:STN:280:DyaK2M7kt1emtg%3D%3D 7840354
8. SA Checkley 1980 Neuroendocrine tests of monoamine function in man: a review of basic theory and its application to the study of depressive illness Psychol Med 10 35 53 10.1017/S0033291700039593 1:CAS:528:DyaL3cXhsFOqtLk%3D 6247735
9. KL Davis RS Kahn G Ko M Davidson 1991 Dopamine in schizophrenia: a review and reconceptualization Am J Psychiatry 148 1474 1486 1:STN:280: DyaK38%2Fis1GksQ%3D%3D 1681750
10. V Di Matteo G Di Giovanni M Pierucci E Esposito 2008 Serotonin control of central dopaminergic function: focus on in vivo microdialysis studies Prog Brain Res 172 7 44 10.1016/S0079-6123(08)00902-3 18772026
11. E Esposito V Di Matteo G Di Giovanni 2008 Serotonin-dopamine interaction: an overview Prog Brain Res 172 3 6 10.1016/S0079-6123(08)00901-1 1:CAS:528:DC%2BD1cXhsV2isbrI 18772025
12. MH Giard J Lavikainen K Reinikainen F Perrin O Bertrand J Pernier R Näätänen 1995 Separate representation of stimulus frequency, intensity and duration in auditory sensory memory: an event-related potential and dipole-model analysis J Cogn Neurosci 7 133 143 10.1162/jocn.1995.7.2.133
13. AA Grace 1991 Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia Neuroscience 41 1 24 10.1016/0306-4522(91)90196-U 1:CAS:528:DyaK3MXisVGiur8%3D 1676137
14. BP Guiard M El Mansari Z Merali P Blier 2008 Functional interactions between dopamine, serotonin and norepinephrine neurons: an in-vivo electrophysiological study in rats with monoaminergic lesions Int J Neuropsychopharmacol 11 5 625 639 10.1017/S1461145707008383 1:CAS:528: DC%2BD1cXnvFehtrc%3D 18205979
15. CJ Harmer SF McTavish L Clark GM Goodwin PJ Cowen 2001 Tyrosine depletion attenuates dopamine function in healthy volunteers Psychopharmacology (Berl) 154 105 111 10.1007/s002130000613 1:CAS:528:DC%2BD3MXjsVert78%3D
16. BJ Harrison JS Olver TR Norman GD Burrows KA Wesnes PJ Nathan 2004 Selective effects of acute serotonin and catecholamine depletion on memory in healthy women J Psychopharmacol 18 32 40 10.1177/0269881104040225 1:CAS:528:DC%2BD2cXktl2qs7g%3D 15107182
17. JM Hughes C Matrenza AH Kemp BJ Harrison D Liley PJ Nathan 2004 Selective effects of simultaneous monoamine depletion on mood and emotional responsiveness Int J Neuropsychopharmacol 7 9 17 10.1017/S1461145703003845 1:CAS:528:DC%2BD2cXhtlKgsrY%3D 14731308
18. DC Javitt SR Zukin 1991 Recent advances in the phencyclidine model of schizophrenia Am J Psychiatry 148 10 1301 1308 1:STN:280:DyaK3MznslymsA%3D%3D 1654746
19. DC Javitt P Doneshka I Zylberman W Ritter HG Vaughan Jr 1993 Impairment of early cortical processing in schizophrenia: an event-related potential confirmation study Biol Psychiatry 33 513 519 10.1016/0006-3223(93)90005-X 1:STN:280:DyaK3s3ptFaqug%3D%3D 8513035
20. DC Javitt M Steinschneider CE Schroeder JC Arezzo 1996 Role of cortical N-methyl-D-aspartate receptors in auditory sensory memory and mismatch negativity generation: implications for schizophrenia Proc Natl Acad Sci USA 93 11962 11967 10.1073/pnas.93.21.11962 1:CAS:528:DyaK28XmtlaksLk%3D 8876245
21. S Kähkönen J Ahveninen IP Jaaskelainen S Kaakkola R Naatanen J Huttunen E Pekkonen 2001 Effects of haloperidol on selective attention: a combined whole-head MEG and high-resolution EEG study Neuropsychopharmacology 25 498 504 10.1016/S0893-133X(01)00255-X 11557163
22. S Kähkönen J Ahveninen E Pekkonen S Kaakkola J Huttunen RJ Ilmoniemi IP Jääskeläinen 2002 Dopamine modulates involuntary attention shifting and reorienting: an electromagnetic study Clin Neurophysiol 113 1894 1902 10.1016/S1388-2457(02)00305-X 12464326
23. S Kähkönen V Makinen IP Jaaskelainen S Pennanen J Liesivuori J Ahveninen 2005 Serotonergic modulation of mismatch negativity Psychiatry Res 138 61 74 10.1016/j.pscychresns.2004.09.006 15708302
24. S Kapur G Remington 1996 Serotonin-dopamine interaction and its relevance to schizophrenia Am J Psychiatry 153 466 476 1:STN:280:DyaK287nvFWmtA%3D%3D 8599393
25. S Kapur P Seeman 2002 NMDA receptor antagonists ketamine and PCP have direct effects on the dopamine D(2) and serotonin 5-HT(2)receptors-implications for models of schizophrenia Mol Psychiatry 7 837 844 10.1038/sj.mp.4001093 1:CAS:528:DC%2BD38XntVaitb4%3D 12232776
26. VJ Knott AL Howson M Perugini AV Ravindran SN Young 1999 The effect of acute tryptophan depletion and fenfluramine on quantitative EEG and mood in healthy male subjects Biol Psychiatry 46 229 238 10.1016/S0006-3223(98)00338-2 1:CAS:528:DyaK1MXltFOlt7c%3D 10418698
27. M Korostenskaja VV Nikulin D Kicic AV Nikulina S Kahkonen 2007 Effects of NMDA receptor antagonist memantine on mismatch negativity Brain Res Bull 72 275 283 10.1016/j.brainresbull.2007.01.007 1:CAS:528:DC%2BD2sXkslKks74%3D 17452287
28. M Korostenskaja D Kicić S Kähkönen 2008 The effect of methylphenidate on auditory information processing in healthy volunteers: a combined EEG/MEG study Psychopharmacology (Berl) 197 475 486 10.1007/s00213-007-1065-8 1:CAS:528:DC%2BD1cXjsFOnu7g%3D
29. I Kreitschmann-Andermahr T Rosburg U Demme E Gaser H Nowak H Sauer 2001 Effect of ketamine on the neuromagnetic mismatch field in healthy humans Brain Res Cogn Brain Res 12 109 116 10.1016/S0926-6410(01)00043-X 1:CAS:528: DC%2BD3MXlslGgu74%3D 11489614
30. S Leung RJ Croft T Baldeweg PJ Nathan 2007 Acute dopamine D(1) and D(2) receptor stimulation does not modulate mismatch negativity (MMN) in healthy human subjects Psychopharmacology (Berl) 194 443 451 10.1007/s00213-007-0865-1 1:CAS:528:DC%2BD2sXhtVynur%2FN
31. S Leung RJ Croft BV O'Neill PJ Nathan 2008 Acute high-dose glycine attenuates mismatch negativity (MMN) in healthy human controls Psychopharmacology (Berl) 196 451 460 10.1007/s00213-007-0976-8 1:CAS:528:DC%2BD1cXht1Knsbo%3D
32. M Leyton VK Pun C Benkelfat SN Young 2003 A new method for rapidly and simultaneously decreasing serotonin and catecholamine synthesis in humans J Psychiatry Neurosci 28 464 467 14631457
33. M Leyton A Dagher I Boileau K Casey GB Baker M Diksic R Gunn SN Young C Benkelfat 2004 Decreasing amphetamine-induced dopamine release by acute phenylalanine/tyrosine depletion: a PET/[11C]raclopride study in healthy men Neuropsychopharmacology 29 427 432 1:CAS:528:DC%2BD2cXksl2htg%3D%3D 14583741
34. GA Light DL Braff 2005a Mismatch negativity deficits are associated with poor functioning in schizophrenia patients Arch Gen Psychiatry 62 127 136 10.1001/archpsyc.62.2.127
35. GA Light DL Braff 2005b Stability of mismatch negativity deficits and their relationship to functional impairments in chronic schizophrenia Am J Psychiatry 162 1741 1743 10.1176/appi.ajp.162.9.1741
36. C Mann RJ Croft KE Scholes A Dunne BV O'Neill S Leung D Copolov KL Phan PJ Nathan 2008 Differential effects of acute serotonin and dopamine depletion on prepulse inhibition and p50 suppression measures of sensorimotor and sensory gating in humans Neuropsychopharmacology 33 1653 1666 10.1038/sj.npp.1301556 1:CAS:528:DC%2BD1cXlvVSrtL4%3D 17895917
37. C Matrenza JM Hughes AH Kemp KA Wesnes BJ Harrison PJ Nathan 2004 Simultaneous depletion of serotonin and catecholamines impairs sustained attention in healthy female subjects without affecting learning and memory J Psychopharmacol 18 21 31 10.1177/0269881104040215 1:CAS:528:DC%2BD2cXktl2qs7o%3D 15107181
38. SF McTavish L Callado PJ Cowen T Sharp 1999a Comparison of the effects of alpha-methyl-p-tyrosine and a tyrosine-free amino acid load on extracellular noradrenaline in the rat hippocampus in vivo J Psychopharmacol 13 379 384 10.1177/026988119901300408 1:CAS:528:DC%2BD3cXhtVerurs%3D
39. SF McTavish PJ Cowen T Sharp 1999b Effect of a tyrosine-free amino acid mixture on regional brain catecholamine synthesis and release Psychopharmacology (Berl) 141 182 188 10.1007/s002130050823 1:CAS:528:DyaK1MXhtFyns74%3D
40. SF McTavish MH McPherson CH Harmer L Clark T Sharp GM Goodwin PJ Cowen 2001a Antidopaminergic effects of dietary tyrosine depletion in healthy subjects and patients with manic illness Br J Psychiatry 179 356 360 10.1192/bjp.179.4.356 1:STN:280:DC%2BD3Mrjtl2gtQ%3D%3D
41. SF McTavish B Raumann PJ Cowen T Sharp 2001b Tyrosine depletion attenuates the behavioural stimulant effects of amphetamine and cocaine in rats Eur J Pharmacol 424 115 119 10.1016/S0014-2999(01)01105-0 1:CAS:528: DC%2BD3MXltlOht7c%3D
42. MA Mehta D Gumaste AJ Montgomery SF McTavish PM Grasby 2005 The effects of acute tyrosine and phenylalanine depletion on spatial working memory and planning in healthy volunteers are predicted by changes in striatal dopamine levels Psychopharmacology (Berl) 180 654 663 10.1007/s00213-004-2128-8 1:CAS:528:DC%2BD2MXhtVSqt7%2FF
43. PT Michie TW Budd J Todd D Rock H Wichmann J Box AV Jablensky 2000 Duration and frequency mismatch negativity in schizophrenia Clin Neurophysiol 111 1054 1065 10.1016/S1388-2457(00)00275-3 1:STN:280:DC%2BD3c3os1Onsg%3D%3D 10825713
44. E Moja D Stoff G Gessa D Castoldi R Assereto O Tofanetti 1988 Decrease in plasma tryptophan after tryptophan-free amino acid mixtures in man Life Sci 42 16 1551 1556 10.1016/0024-3205(88)90013-6 1:CAS:528:DyaL1cXit1Sksb4%3D 3352467
45. AJ Montgomery SF McTavish PJ Cowen PM Grasby 2003 Reduction of brain dopamine concentration with dietary tyrosine plus phenylalanine depletion: an [11C]raclopride PET study Am J Psychiatry 160 1887 1889 10.1176/appi.ajp.160.10. 1887 14514507
46. Näätänen R (1992) Attention and brain function. Lawrence Erlbaum Associates, Hillsdale
47. R Näätänen 2000 Mismatch negativity (MMN): perspectives for application Int J Psychophysiol 37 3 10 10.1016/S0167-8760(00)00091-X 10828371
48. R Näätänen PT Michie 1979 Early selective-attention effects on the evoked potential: a critical review and reinterpretation Biol Psychol 8 81 136 10.1016/0301-0511(79)90053-X 465623
49. R Näätänen I Winkler 1999 The concept of auditory stimulus representation in cognitive neuroscience Psychol Bull 125 826 859 10.1037/0033-2909.125.6.826 10589304
50. PJ Nathan JM Hughes B McInerney BJ Harrison 2004 Simultaneous depletion of tryptophan, tyrosine and phenylalanine as an experimental method to probe brain monoamine function in humans Int J Neuropsychopharmacol 7 171 176 10.1017/S1461145703004073 1:CAS:528:DC%2BD2cXjs12mtbc%3D 14962353
51. AH Neuhaus TE Goldberg Y Hassoun JA Bates KW Nassauer S Sevy C Opgen-Rhein AK Malhotra 2009 Acute dopamine depletion with branched chain amino acids decreases auditory top-down event-related potentials in healthy subjects Schizophr Res 111 1-3 167 173 10.1016/j.schres.2009.03.023 19356906
52. S Nishizawa C Benkelfat SN Young M Leyton S Mzengeza C De Montigny P Blier M Diksic 1997 Differences between males and females in rates of serotonin synthesis in human brain Proc Natl Acad Sci USA 94 5308 5313 10.1073/pnas.94.10.5308 1:CAS:528:DyaK2sXjtlelt7Y%3D 9144233
53. BV O'Neill V Guille RJ Croft S Leung KE Scholes K Phan PJ Nathan 2008 Effects of selective and combined serotonin and dopamine depletion on the loudness dependence of the auditory evoked potential (LDAEP) in humans Hum Psychopharmacol 23 301 312 10.1002/hup.926 18213738
54. B Oranje BNM van Bercekl C Kemner JM van Ree RS Kahn MN Verbaten 2000 The effects of a sub-anaesthetic dose of ketamine on human selective attention Neuropsychopharmacology 22 293 302 10.1016/S0893-133X(99)00118-9 1:CAS:528:DC%2BD3cXhtFagtLg%3D 10693157
55. B Oranje K Jensen M Wienberg BY Glenthoj 2008 Divergent effects of increased serotonergic activity on psychophysiological parameters of human attention Int J Neuropsychopharmacol 11 453 463 10.1017/S1461145707008176 1:CAS:528:DC%2BD1cXmt1Kqtrs%3D 17971261
56. EW Pang B Fowler 1999 Dissociation of the mismatch negativity and processing negativity attentional waveforms with nitrous oxide Psychophysiology 36 552 558 10.1017/S0048577299971172 1:STN:280:DyaK1MzntVKisw%3D%3D 10442023
57. E Pekkonen J Hirvonen J Ahveninen S Kähkönen S Kaakkola J Huttunen IP Jääskeläinen 2002 Memory-based comparison process not attenuated by Haloperidol: a combined MEG and EEG study NeuroReport 13 177 181 10.1097/00001756-200201210-00040
58. T Rinne K Alho RJ Ilmoniemi J Virtanen R Näätänen 2000 Separate time behaviors of the temporal and frontal mismatch negativity sources Neuroimage 12 14 19 10.1006/nimg.2000.0591 1:STN:280:DC%2BD3cvhtVeqtQ%3D%3D 10875898
59. G Roccatagliata C Albano L Cocito M Maffini 1979 Interactions between central monoaminergic systems: dopamine-serotonin J Neurol Neurosurg Psychiatry 42 1159 1162 10.1136/jnnp.42.12.1159 1:CAS:528:DyaL3cXhtVCmtLo%3D 160445
60. A Sambeth A Blokland CJ Harmer TO Kilkens PJ Nathan RJ Porter JA Schmitt B Scholtissen S Sobcza AH Young WJ Riedel 2007 Sex differences in the effect of acute tryptophan depletion on declarative episodic memory: a pooled analysis of nine studies Neurosci Biobehavl Rev 31 516 529 10.1016/j.neubiorev.2006.11.009 1:CAS:528:DC%2BD2sXjvFGmsL0%3D
61. A Schirmer N Escoffier QY Li H Li J Strafford-Wilson L Wi 2008 What grabs his attention but not hers? Estrogen correlates with neurophysiological measures of vocal change detection Psychoneuroendocrinology. 33 6 718 727 10.1016/j.psyneuen.2008.02.010 1:CAS:528:DC%2BD1cXosVyjsbc%3D 18395352
62. KE Scholes BJ Harrison BV O'Neill S Leung RJ Croft A Pipingas KL Phan PJ Nathan 2007 Acute serotonin and dopamine depletion improves attentional control: findings from the stroop task Neuropsychopharmacology 32 1600 1610 10.1038/sj.npp.1301262 1:CAS:528:DC%2BD2sXms1Slu7s%3D 17151596
63. AM Shelley PB Ward SV Catt PT Michie S Andrews N McConaghy 1991 Mismatch negativity: an index of a preattentive processing deficit in schizophrenia Biol Psychiatry 30 1059 1062 10.1016/0006-3223(91)90126-7 1:STN:280: DyaK38%2Fps1Gjtw%3D%3D 1756198
64. J Sinkkonen M Tervaniemi 2000 Towards optimal recording and analysis of the mismatch negativity Audiol Neurootol 5 235 246 10.1159/000013885 1:STN:280:DC%2BD3cvgt1Omsg%3D%3D 10859418
65. RL Spitzer JB Williams K Kroenke M Linzer FV deGruy 3rd SR Hahn D Brody JG Johnson 1994 Utility of a new procedure for diagnosing mental disorders in primary care. The PRIME-MD 1000 study JAMA 272 1749 1756 10.1001/jama.272.22. 1749 1:STN:280:DyaK2M%2Fls1eqsQ%3D%3D 7966923
66. Tabachnick BG, Fidell LS (2001) Using multivariate statistics. Allyn and Bacon, Boston
67. G Tsai JT Coyle 2002 Glutamatergic mechanisms in schizophrenia Annu Rev Pharmacol Toxicol 42 165 179 10.1146/annurev.pharmtox.42.082701.160735 1:CAS:528:DC%2BD38XhvFKnsbw%3D 11807169
68. D Umbricht S Krljes 2005 Mismatch negativity in schizophrenia: a meta-analysis Schizophr Res 76 1 23 10.1016/j.schres.2004.12.002 15927795
69. D Umbricht D Javitt G Novak J Bates S Pollack J Lieberman J Kane 1998 Effects of clozapine on auditory event-related potentials in schizophrenia Biol Psychiatry 44 716 725 10.1016/S0006-3223(97)00524-6 1:CAS:528:DyaK1cXntlWmuro%3D 9798075
70. D Umbricht D Javitt G Novak J Bates S Pollack J Lieberman J Kane 1999 Effects of risperidone on auditory event-related potentials in schizophrenia Int J Neuropsychopharmacol 2 299 304 10.1017/S1461145799001595 1:CAS:528: DC%2BD3cXnsVKktQ%3D%3D 11285146
71. D Umbricht L Schmid R Koller FX Vollenweider D Hell DC Javitt 2000 Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers: implications for models of cognitive deficits in schizophrenia Arch Gen Psychiatry 57 1139 1147 10.1001/archpsyc.57.12.1139 1:CAS:528:DC%2BD3MXhsFah 11115327
72. D Umbricht R Koller FX Vollenweider L Schmid 2002 Mismatch negativity predicts psychotic experiences induced by NMDA receptor antagonist in healthy volunteers Biol Psychiatry 51 400 406 10.1016/S0006-3223(01)01242-2 1:CAS:528:DC%2BD38XitFaqs7g%3D 11904134
73. 2A agonist psilocybin on mismatch negativity generation and AX-continuous performance task: implications for the neuropharmacology of cognitive deficits in schizophrenia Neuropsychopharmacology 28 170 181 10.1038/sj.npp.1300005 1:CAS:528:DC%2BD3sXhtlWitrY%3D 12496954
74. Wienberg M, Glenthoj B, Jensen K, Oranje B (2009) A single high dose of escitalopram increases mismatch negativity without affecting processing negativity or P300 amplitude in healthy volunteers. J Psychopharmacol. doi: 10.1177/0269881109102606
75. WA Williams SE Shoaf D Hommer R Rawlings M Linnoila 1999 Effects of acute tryptophan depletion on plasma and cerebrospinal fluid tryptophan and 5-hydroxyindoleacetic acid in normal volunteers J Neurochem 72 1641 1647 10.1046/j.1471-4159.1999.721641.x 1:CAS:528:DyaK1MXitFCksbc%3D 10098872
76. I Winkler 2007 Interpreting the mismatch negativity J Psychophys 21 147 163 10.1027/0269-8803.21.34.147
77. G Winterer 2006 Cortical microcircuits in schizophrenia-the dopamine hypothesis revisited Pharmacopsychiatry 39 Suppl 1 S68 S71 10.1055/s-2006-931498 16508900
78. G Winterer DR Weinberger 2004 Genes, dopamine and cortical signal-to-noise ratio in schizophrenia Trends Neurosci 27 683 690 10.1016/j.tins.2004.08.002 1:CAS:528:DC%2BD2cXotlajsbo%3D 15474169
79. SN Young SE Smith RO Pihl FR Ervin 1985 Tryptophan depletion causes a rapid lowering of mood in normal males Psychopharmacology (Berl) 87 173 177 10.1007/BF00431803 1:CAS:528:DyaL2MXlsFyhtr8%3D